Physician profile
Craig Springmeyer
NPI 1487658241
$6,494.12
in general payments reported to CMS, 2019-2025
15 companies · $98.15 in 2025
The $98.15 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,528 · 2020: $2,517 · 2021: $647 · 2022: $577 · 2023: $479 · 2024: $648 · 2025: $98.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,014.14 | 2019-2025 | Mako, Infinity, Aequalis Ascend Flex |
| Arthrex, INC. | $1,886.12 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $168.10 | 2021-2024 | Iovera, Zilretta, Exparel |
| Midsouth Orthopedics INC. | $136.43 | 2020 | |
| Innovation Technologies INC | $41.06 | 2024-2025 | Irrisept |
| Nalu Medical, INC. | $39.20 | 2025 | Nalu Neurostimulation System |
| Dynasplint Systems INC. | $37.50 | 2023 | Dynasplint |
| Abbott Laboratories | $33.94 | 2019-2025 | Eterna |
| Davol INC. | $26.08 | 2022 | |
| Welch Allyn | $24.97 | 2021 | |
| Vericel Corporation | $23.81 | 2021 | |
| Smith+Nephew, INC. | $22.18 | 2020 | |
| Amgen INC. | $15.92 | 2023 | Prolia, Evenity |
| Horizon Therapeutics Plc | $13.06 | 2020 | |
| Pfizer INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Springmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.